Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its price objective cut by investment analysts at JPMorgan Chase & Co. from $47.00 to $39.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of […]
The experiences of the thousands of laid-off biopharmaceutical workers in Massachusetts provide a snapshot of a sector that is settling down after years of hope and hype.
Tango Therapeutics, Inc (TNGX) Announces FDA Clearance of Investigational New Drug Application for TNG348 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.